A customer from spain alleged discrepant results with one sample using with the cobas egfr mutation test v2.The alleged sample is from a patient who was previously diagnosed with the ex19del mutation in order to detect if any resistance mutations developed.When testing the sample from the first extraction of cfdna, the result was mutation detected for t790m mutation only.The customer repeated the cfdna extraction to re-test the sample.In this case, the result was mutation detected for ex19del, but the t790m mutation was not detected.Subsequently, a new blood collection was performed and the sample was re-tested in duplicate.The results were 1) ex19del and t790m mutations detected and 2) ex19del mutation detected and t790m was not detected.No harm or injury alleged.
|
The investigation of the reagents did not show any product malfunction.The t790m mutation discrepancy is due to a low number of mutations in the sample; the ctr values are near the lod of the assay, which may cause varying results.The root cause of the mutation not detected (nan) in the initial run on (b)(6) 2022 for the ex19del is unknown.In all subsequent testing of the sample, the ex19del was present and generated robust ct values.The ex19del discrepancy could be related to workflow practices.
|